European Approval for Sydnexis’ Pediatric Myopia Treatment
Sydnexis’ SYD-101 low-dose atropine formulation is now the first pharmaceutical option in Europe for myopia. The European Commission has granted…
Taiwan’s Vision for Myopia Control: Prof. Maria Liu on MiSight® 1 Day Contact Lenses
In this satellite session recording from Taiwan, distinguished University of California Berkeley Prof. Maria Liu shares the clinical rationale, practical…
popular posts
latest posts
